Product and Company News from the 7/22 News Brief

Product News

Biopharmaceutical company QLT announced that it has received final approval from the FDA to market Aczone (dapsone) Gel, for the topical treatment of acne vulgaris.

Company news

Allergan and Pharmacopeia have reached an agreement to research compounds for age-related macular degeneration (AMD). Allergan seeks to strengthen its ocular diseases franchise via possible future acquisitions of Pharmacopeia's novel compounds targeting angiogenesis.

AstraZeneca has agreed to pay up to $340m in cash and conditional milestone payments to Avanir, to license compounds for cardiovascular disease.

You must be a registered member of MMM to post a comment.

Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.

Email Newsletters